Expression of antisense RNA to aldehyde dehydrogenase class-1 sensitizes tumor cells to 4-hydroperoxycyclophosphamide in vitro

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 2, 2000, Pages 390-396

  Moreb, Jan S ^a   Maccow, Chalesea ^a   Schweder, Mark ^a   Hecomovich, Jaima ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE INHIBITOR; COMPLEMENTARY DNA; COMPLEMENTARY RNA; CYCLOPHOSPHAMIDE; DIETHYLAMINOBENZALDEHYDE; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN K 562; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SENSITIZATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE OVEREXPRESSION; GENETIC MANIPULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL;

ALDEHYDE DEHYDROGENASE; ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CYCLOPHOSPHAMIDE; DNA, NEOPLASM; GENETIC VECTORS; HUMANS; LEUKEMIA, EXPERIMENTAL; LUNG NEOPLASMS; RNA, ANTISENSE; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034099052     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Arndt GM and Hank GN (1997) Colocalization of antisense ENAs and ribozymes with their target mRNAs. Genome 40:785-797.
2. Berggren K, McCaffery P, Dragger U and Forehand CJ (1999) Differential distribution of retinoic acid synthesis in the chicken embryo as determined by immunolocalization of the retinoic acid synthetic enzyme, RALDH-2. Dev Biol 210:288-304.
3. Bhat PV, Poissant L and Wang XL (1996) Purification and partial characterization of bovine kidney aldehyde dehydrogenase able to oxidize retinal to retinoic acid. Biochem Cell Biol 74:695-700.
4. Bunting KD and Townsend AJ (1996) Protection by transfected rat or human class 3 aldehyde dehydrogenase against the cytotoxic effects of oxazaphosphorine alkylating agents in hamster V79 cell lines. Demonstration of aldophosphamide metabolism by the human cytosolic class 3 isozyme. J Biol Chem 271:11891-11896.
5. Chen L, Waxman DJ, Chen D and Kufe DW (1996) Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene. Cancer Res 56:1331-1340.
6. Ch'ng JLC, Mulligan RC, Schemmel P and Holmes EW (1989) Antisense RNA complementary to 3′ coding and noncoding sequences of creatine kinase is a potent inhibitor of translation in vivo. Proc Natl Acad Sci USA 86:10006-10010.
7. Chomczynski P and Sacchi N (1987) Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
8. Crucio LD, Bouffard DY and Scanlon KJ (1997) Oligonucleotides as modulators of cancer gene expression. Pharmacol Ther 74:317-332.
9. Friedman HS, Colvin OM, Kaufmann SH, Ludeman SM, Bullock N, Bigner DD and Griffith OW (1992) Cyclophosphamide resistance in medulloblastoma. Cancer Res 52:5373-5378.
10. Kohn FR and Sladek NE (1985) Aldehyde dehydrogenase activity as the basis for the relative insensitivity of murine pluripotent hematopoietic stem cells to oxazaphosphorines. Biochem Pharmacol 34:3465-3471.
11. Labrecque J, Dumas F, Lacroix A and Bhat PV (1995) A novel isozyme of aldehyde dehydrogenase specificaly involved in the biosynthesis of 9-cis and all-transretinoic acid. Biochem J 305:681-684.
12. Lee M-O, Manthey CL and Sladek NE (1991) Identification of mouse liver aldehyde dehydrogenases that catalyze the oxidation of retinaldehyde to retinoic acid. Biochem Pharmacol 42:1279-1285.
13. Magni M, Shammah S, Schiro R, Mellado W, Dallafavera R and Gianni AM (1996) Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood 3:1097-1103.
14. McCaffery P, Wagner E, O'Neil J, Petkovich M and Drager US (1999) Dorsal and ventral retinal territories defined by retinoic acid synthesis, break-down and nuclear receptor expression. Mech Dev 85:203-214.
15. McGowan AT and Fox BW (1986) A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro. Cancer Chemother Pharmacol 17:223-226.
16. Mercola D and Cohen JS (1995) Antisense approaches to cancer gene therapy. Cancer Gene Ther 2:47-59.
17. Miller AD and Rosman GJ (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980-990.
18. Moreb JS, Schweder M, Gray B, Zucali JR and Zori R (1998) In vitro selection for K562 cells with higher retrovirally mediated copy number of aldehyde dehydrogenase class-1 and higher resistance to 4-hydroperoxycyclophosphamide. Human Gene Ther 9:611-619.
19. Moreb J, Schweder M, Suresh A and Zucali JR (1996) Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperyoclophosphamide. Cancer Gene Ther 3:24-30.
20. Moreb JS, Turner C, Sreerama L, Zucali JR, Sladek NE and Schweder M (1995) Interleukin-1 and tumor necrosis factor alpha induce class 1 aldehyde dehydrogenase mRNA and protein in bone marrow cells. Leuk Lymphoma 20:77-84.
21. O'Conner PM, Ferris DK, White GA, Pines J, Hunter T, Longo DL and Kohn KW (1992) Relationships between cdc 2 kinase, DNA cross linking, and cell cycle perturbations induced by nitrogen mustard. Cell Growth Differ 3:43-52.
22. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KMW, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM, Han C-I, Martin FD, Yen N, Xu K, Stephens LC, Mcdonnell T, Mukhopadhyay T and Cai D (1996) Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 2:985-991.
23. Russo JE and Hilton J (1988) Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide-resistant L1210 cells. Cancer Res 48:1962-1968.
24. Shaki-Eshleman SH and Liebhaber SA (1988) Influence of duplexes 3′ to the mRNA initiation codon on the efficiency of monosome formation. Biochemistry 27:3975-3982.
25. Sladek NE and Landkamer GJ (1985) Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant P388 cell lines. Cancer Res 45:1549-1555.
26. Sreerama L and Sladek NE (1997) Class 1 and class 3 aldehyde dehydrogenase levels in the human tumor cell lines currently used by the National Cancer Institute to screen for potentially useful anti-tumor agents. Adv Exp Med Biol 414:81-94.
27. Tonkinson JL and Stein CA (1996) Antisense oligodeoxynucleotides as clinical therapeutic agents. Cancer Invest 14:54-65.
28. Tursz T, Cesne A, Baldeyrou P, Gautier E, Opolon P, Schatz C, Pavirani A, Courtney M, Lamy D, Ragot T, Saulnier P, Andermont A, Monier R, Perricaudet M and Le Chevalier T (1996) Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients. J Natl Cancer Inst 88:1857-1863.
29. Yuan ZM, Fensdau C, Dulik DM, Martin W, Emary WB, Brundrett RB, Colvin OM and Cotter RJ (1990) Laser desorption electron impact: Application to a study of the mechanism of conjugation of glutathione and cyclophosphamide. Anal Chem 62:868-870.
30. Zhang WW (1996) Antisense oncogene and tumor suppressor gene therapy for cancer. J Mol Med 74:191-204.
31. Zhao D, McCaffery P, Ivins KJ, Neve RL, Hogan P, Chin WW and Drager UC (1996) Molecular identification of a major retinoic-acid-synthesizing enzyme, a retinal-dehyde-specific dehydrogenase. Eur J Biochem 240:15-22.